“Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 – Type I Interferon Pathway”. Cardiology and Cardiovascular Medicine 6, no. 4 (August 25, 2022): 416–423. Accessed September 18, 2026. https://fortunejournals.org/ojs/index.php/ccm/article/view/16285.